Purchase Order 75N95019P00242
Award Date 4/9/19
Potential Completion Date 7/8/19
Potential Value $133K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $127,908.40 firm fixed-price purchase order awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The award is for Promega's proprietary reagent kits and assay products, which are sole source procured due to their specialized capabilities required to support NCATS' ongoing laboratory research and high-throughput screening programs. This award was not...
- This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Promega Corporation, a global life sciences company, to provide P450-Glo screening systems including CYP26A1, CYP26B1, and CYP3A4 assay kits. The $123,592.50 contract supports the Tox21 collaboration between NCATS, the National Toxicology Program, EPA, and FDA, which aims to screen thousands of compounds in vitro to develop better toxicity...
- This firm-fixed-price purchase order was awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS) within the Department of Health and Human Services' National Institutes of Health. The $121,492.50 contract is for the procurement of detection assay systems with an August 2021 completion date. Promega has previously been awarded prime and subcontracts by various agencies including the NIH, CDC, DoD, and FBI to provide DNA...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed-price purchase order to Promega Corporation for P450-Glo Assay Systems. The $143,461.50 contract is for the supply of 65 units each of CYP3A4, CYP2D6, and CYP1A2 assay kits to support the Toxicology in the 21st Century (Tox21) program's efforts to screen compounds for effects on cytochrome P450 enzyme activities. Promega is a global life sciences...
- The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $55,800 firm-fixed-price purchase order contract to Promega Corporation for the supply of P450-Glo CYP26A1 and CYP26B1 Screening Systems. This non-competitive contract, awarded without set-aside, will provide NCATS with specialized laboratory equipment and reagents to support its biomedical research and testing programs. Promega, a global life sciences company, is a...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) on behalf of the National Center for Advancing Translational Sciences (NCATS) to Promega Corporation, a global life sciences company. The $83,800 contract is for the procurement of Promega reagents and assays to support NCATS' Antiviral Program for Pandemics. The award does not utilize a set-aside designation. The original solicitation states that NCATS' screening assays have been optimized using Promega...
- Promega Corporation received a contract award valued at $21,260 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, on April 12, 2016. This firm fixed-price BPA (Blanket Purchase Agreement) call was issued without small business set-aside designation and required performance in Madison, Wisconsin, with completion by February 28, 2017. The contract procures specialized kinase assay products including ADP-Glo Kinase Assay kits...
- The National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, awarded a Firm Fixed Price Purchase Order contract to Promega Corporation, a for-profit manufacturer of biological research and diagnostic products. The $66,970.35 contract is for the delivery of Promega's proprietary laboratory equipment, reagents, and consumables to support the agency's biomedical research and testing programs. This award is under a $10 million...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Promega Corporation for a methyltransferase assay kit, consisting of 2,000 assays. The $45,504.00 contract is to support NCATS' mission of catalyzing innovative methods and technologies for developing diagnostics and therapeutics. The assay kits will be used in NCATS' methyltransferase project to identify...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order contract to Promega Corporation, a global life sciences company, for the provision of reagent kits and assays. The contract has a potential value of $22,784.00 and a completion date of July 21, 2020. Promega has previously provided DNA analysis equipment, reagents, assays, and related laboratory supplies to federal agencies...